Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
James Davis Rolfe Insider Profile
4 Followers
James Davis Rolfe, Chief Development Officer at Medical Facilities, holds 379.00K shares in Medical Facilities (Ticker: MFCSF).
James Davis Rolfe has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of James Davis Rolfe's holdings
Insider Roles
Chief Development Officer
Roles that James Davis Rolfe holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 20, 2020 - Mar 20, 2021
Return:+165.00%
The most profitable trade made by James Davis Rolfe
James Davis Rolfe's Trading History
List of latest transactions for each holding click on a transaction to see James Davis Rolfe's performance on stock
You May Also Like
James Davis Rolfe insider profile FAQ
What is the percentage of profitable transactions made by James Davis Rolfe?
The percentage of profitable transactions made by James Davis Rolfe is ―.
What is the average return per transaction made by James Davis Rolfe?
The average return per transaction made by James Davis Rolfe is ―.
What stocks does James Davis Rolfe hold?
James Davis Rolfe holds: MFCSF stocks.
What was James Davis Rolfe’s latest transaction?
James Davis Rolfe latest transaction was an Uninformative Sell of ―.
What was James Davis Rolfe's most profitable transaction?
James Davis Rolfe’s most profitable transaction was an Informative Buy of MFCSF stock on March 20, 2020. The return on the trade was 165.00%.
What is James Davis Rolfe's role in Medical Facilities?
James Davis Rolfe's role in Medical Facilities is Chief Development Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.